Compare Box Inc (BOX) vs Invesco Ltd. (IVZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Box Inc vs Invesco Ltd. — how do they compare? Box Inc trades at $32.52 (market cap $4.65B), while Invesco Ltd. trades at $31.16 (market cap $14.01B). The key difference: Invesco Ltd. is far larger — about 3× Box Inc's market cap, and Invesco Ltd. pays a 2.71% dividend while Box Inc pays none. Which is the better fit depends on your goals.
| BOX | IVZ | |
|---|---|---|
Market Cap | $4.65B | $14.01B |
Sector | Technology | Financials |
52-Week High | $33.60 | $32.01 |
52-Week Low | $21.37 | $20.67 |
Enterprise Value | $5.21B | $24.18B |
Dividend Yield | — | 2.71% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Box Inc
Box is a cloud-based content services platform that provides cloud-based storage and workflow collaboration services for enterprise customers. The firm was founded in 2005 as a file sync and sharing provider. More recently, however, the company has focused on bolstering its product portfolio by adding tools such as governance and e-signature that enhance workflow management and collaboration.
Read more on BOX →About Invesco Ltd.
Invesco provides investment-management services to retail (65% of managed assets) and institutional (35%) clients. At the end of August 2022, the firm had $1.416 trillion in assets under management spread among its equity (47% of AUM), balanced (5%), fixed-income (22%), alternative investment (14%), and money market (12%) operations. Passive products account for 32% of Invesco's total AUM, including 56% of the company's equity operations and 13% of its fixed-income platform. Invesco's U.S. retail business is one of the 10 largest nonproprietary fund complexes in the country. The firm also has a meaningful presence outside the U.S., with close to one third of its AUM sourced from Canada (2%), the U.K. (4%), continental Europe (11%), and Asia (15%).
Read more on IVZ →
